Related Experiment Video
Updated: Aug 8, 2026

Characteristics of Pain Changes in Rats with Nerve Injury Within 24 hours After One-Time Tuina Intervention
Published on: January 26, 2024
A world without pain or tears
1Dysautonomia Treatment and Evaluation Center, NYU Medical Center, 530 First Avenue, suite 9Q, New York, NY 10016, USA. felicia.axelrod@med.nyu.edu
Insights
Familial dysautonomia (FD) is a genetic disorder impacting the nervous system. Advances in supportive care and genetic research offer improved treatments and prognosis for affected children.
Area of Science:
- Genetics
- Pediatrics
- Neurology
Background:
- Familial dysautonomia (FD) is a rare genetic disorder impacting the sensory and autonomic nervous system development in children.
- Historically, FD has presented significant challenges in morbidity and mortality.
- Recent advancements in genetic understanding offer new therapeutic avenues.
Purpose of the Study:
- To review current supportive treatment modalities for familial dysautonomia.
- To discuss the rationale behind existing treatments.
- To explore innovative, genetically-informed treatment strategies for FD.
Main Methods:
- Literature review of supportive care for FD.
- Analysis of recent genetic research findings.
- Synthesis of current and emerging treatment approaches.
Main Results:
- Supportive treatments have significantly improved survival and quality of life for children with FD over the past 35 years.
- Genetic breakthroughs are paving the way for novel therapeutic strategies.
- New treatments aim to modify genetic expression and alter disease progression.
Conclusions:
- Current supportive care is crucial for managing familial dysautonomia.
- Emerging genetic therapies hold promise for fundamentally altering the prognosis of FD.
- A combination of supportive and genetic-based treatments is key for future management.
Abstract:
The world of the child with familial dysautonomia (FD), a genetic disorder affecting development of the sensory and autonomic nervous system, is not idyllic. However, over the last 35 years advances in supportive treatments have improved morbidity and mortality. Recent genetic breakthroughs have further expanded thinking about this disorder and suggested innovative approaches to modifying genetic expression. This article reviews the current supportive treatment modalities and their rationale, as well as the suggested new treatments that may alter the function and prognosis of an individual affected with FD.
Related Concept Videos
Pain
Nociception
Blood and Nerve Supply to the Bones
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
Analgesia and Pain Management
Healing I: Introduction
Electrolysis

